COMPANY GROWTH PILLARS
CURE Pharmaceutical is pursuing multiple pathways to market in the US:
· 505(b)2 FDA NDA and
· 503B Compound Manufacturing
Pharmaceutical Pipeline - 503B
Functional Food Pipeline
Nutraceutical Products
US
US
Mexico
US
Mexico
US
US
US
Pharmaceutical Pipeline - 503B
Functional Food Pipeline
Nutraceutical Products
US
US
Mexico
US
Mexico
US
US
US
Pharmaceutical Pipeline - 503B
Functional Food Pipeline
Nutraceutical Products
